Financing ·
QuidelOrtho resets financial covenants through 2029 with leverage ratios up to 5.50:1 and interest rates at 1.50% for base loans
QDELQuidelOrtho Corp
On September 23, 2026, QuidelOrtho Corporation entered into Amendment No. 1 to its existing credit agreement with Bank of America and other lenders. The amendment resets financial covenant levels through the fiscal quarter ending September 30, 2029, providing a Covenant Relief Period. During this period, maximum Consolidated Leverage Ratios range from 5.50:1.00 down to 4.25:1.00, while minimum Consolidated Interest Coverage Ratios increase from 2.25:1.00 to 3.00:1.00. The amendment also sets initial interest rates at 1.50% for base rate loans and 2.50% for Term SOFR loans until the first compliance certificate after September 28, 2026. QuidelOrtho operates in the medical diagnostics industry.